Bohm, V; Podlech, J; Thomas, D et al.
Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 135-44
Mersseman, V; Besold, K; Reddehase, MJ et al.
Exogenous introduction of an immunodominant peptide from the non-structural IE1 protein of human cytomegalovirus into the MHC class I presentation pathway by recombinant dense bodies.J Gen Virol. Bd. 89. H. Pt 2. 2008 S. 369-79
Seckert, CK; Renzaho, A; Reddehase, MJ et al.
Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 251-9
Raftery, MJ; Hitzler, M; Winau, F et al.
Inhibition of CD1 antigen presentation by human cytomegalovirusJOURNAL OF VIROLOGY. Bd. 82. H. 9. 2008 S. 4308-4319
Reddehase, MJ; Simon, CO; Seckert, CK et al.
Murine model of cytomegalovirus latency and reactivation.Curr Top Microbiol Immunol. Bd. 325. 2008 S. 315-31
Wirtz, N; Schader, SI; Holtappels, R et al.
Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 151-8
Besold, K; Plachter, B
Recombinant viruses as tools to study human cytomegalovirus immune modulationMed Microbiol Immunol. Bd. 197. H. 2. 2008 S. 215-222
Distler, E; Schnurer, E; Wagner, E et al.
Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.Biol Blood Marrow Transplant. Bd. 14. H. 12. 2008 S. 1417-24
Mersseman, V; Bohm, V; Holtappels, R et al.
Refinement of strategies for the development of a human cytomegalovirus dense body vaccine.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 97-107
Holtappels, R; Simon, CO; Munks, MW et al.
Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.J Virol. Bd. 82. H. 12. 2008 S. 5781-96